Subretinal hyperreflective material (SHRM) in retinal and chorioretinal disorders: A comprehensive review.
Subretinal hyperreflective material
age-related macular degeneration
anti-VEGF therapy
choroidal neovascularisation
macular dystrophies
macular neovascularisation
pachychoroid disease
pathologic myopia
posterior uveitis
vitelliform material
Journal
Survey of ophthalmology
ISSN: 1879-3304
Titre abrégé: Surv Ophthalmol
Pays: United States
ID NLM: 0404551
Informations de publication
Date de publication:
29 Dec 2023
29 Dec 2023
Historique:
received:
19
06
2023
revised:
25
09
2023
accepted:
03
10
2023
medline:
2
1
2024
pubmed:
2
1
2024
entrez:
31
12
2023
Statut:
aheadofprint
Résumé
Subretinal hyperreflective material (SHRM) is a common and remarkable optical coherence tomography (OCT) biomarker whose importance is emerging in several retinal and chorioretinal diseases, including age-related macular degeneration, central serous chorioretinopathy, polypoidal choroidal vasculopathy, pathologic myopia, posterior uveitis, vitelliform lesions and macular dystrophies, and more rare disorders. Multimodal imaging, also thanks to the introduction of OCT angiography, allowed a deeper characterisation of SHRM components and its morphological changes after treatment, suggesting its usefulness in clinical practice. In our review, we discuss and summarize the nature, multimodal imaging characteristics, and prognostic and predictive significance of SHRM in the different retinal and choroidal disorders in which it has been described.
Identifiants
pubmed: 38160737
pii: S0039-6257(23)00169-8
doi: 10.1016/j.survophthal.2023.10.013
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None Declaration of competing interest The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.